QuidelOrtho (QDEL) Accumulated Depreciation & Amortization (2022 - 2026)
QuidelOrtho recorded quarterly Accumulated Depreciation & Amortization of $112.9 million in Q1 2026, down 55.34% quarter-over-quarter from $252.8 million in Q4 2025, and up 5.42% year-over-year from $107.1 million in Q1 2025.
QuidelOrtho's Accumulated Depreciation & Amortization history runs 5 years deep, the most recent figure standing at $112.9 million for Q1 2026.
- In Q1 2026, Accumulated Depreciation & Amortization rose 5.42% year-over-year to $112.9 million; the TTM figure through Mar 2026 stood at $112.9 million (up 5.42% YoY), while the FY2025 annual figure was $252.8 million, up 1.12% from the prior year.
- Accumulated Depreciation & Amortization came in at $112.9 million for Q1 2026 at QuidelOrtho, down from $252.8 million in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $344.1 million in Q3 2024 to a low of $52.7 million in Q1 2022.
- A 5-year average of $164.7 million and a median of $115.5 million in 2024 frame the typical range for Accumulated Depreciation & Amortization.
- Across the five-year window, Accumulated Depreciation & Amortization soared 186.72% in 2023 and plunged 67.42% in 2025, its largest moves.
- QuidelOrtho's Accumulated Depreciation & Amortization stood at $52.7 million in 2022, then jumped by 378.94% to $252.4 million in 2023, then decreased by 0.95% to $250.0 million in 2024, then grew by 1.12% to $252.8 million in 2025, then plunged by 55.34% to $112.9 million in 2026.
- According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods registered $112.9 million, $252.8 million, and $112.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | QuidelOrtho | 898.19 Mn | 757.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 112.90 Mn |
| Mar 29, 2026 | 112.90 Mn |
| Dec 28, 2025 | 252.80 Mn |
| Dec 28, 2025 | 252.80 Mn |
| Sep 28, 2025 | 112.10 Mn |
| Sep 28, 2025 | 112.10 Mn |
| Jun 29, 2025 | 110.30 Mn |
| Jun 29, 2025 | 110.30 Mn |
| Mar 30, 2025 | 107.10 Mn |
| Mar 30, 2025 | 107.10 Mn |
| Dec 29, 2024 | 250.00 Mn |
| Dec 29, 2024 | 250.00 Mn |
| Sep 29, 2024 | 344.10 Mn |
| Sep 29, 2024 | 344.10 Mn |
| Jun 30, 2024 | 116.10 Mn |
| Jun 30, 2024 | 116.10 Mn |
| Mar 31, 2024 | 114.90 Mn |
| Mar 31, 2024 | 114.90 Mn |
| Dec 31, 2023 | 252.40 Mn |
| Dec 31, 2023 | 252.40 Mn |
| Jan 1, 2023 | 151.10 Mn |
| Jan 1, 2023 | 151.10 Mn |
| Jan 2, 2022 | 52.70 Mn |
| Jan 2, 2022 | 52.70 Mn |